192 related articles for article (PubMed ID: 16930551)
1. Human topoisomerase I forms double cleavage complexes on natural DNA.
Søe K; Hartung S; Grosse F
Biochem Biophys Res Commun; 2006 Oct; 349(1):178-85. PubMed ID: 16930551
[TBL] [Abstract][Full Text] [Related]
2. Resolution of Holliday junction substrates by human topoisomerase I.
Hede MS; Petersen RL; Frøhlich RF; Krüger D; Andersen FF; Andersen AH; Knudsen BR
J Mol Biol; 2007 Jan; 365(4):1076-92. PubMed ID: 17101150
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for specificity in the poxvirus topoisomerase.
Perry K; Hwang Y; Bushman FD; Van Duyne GD
Mol Cell; 2006 Aug; 23(3):343-54. PubMed ID: 16885024
[TBL] [Abstract][Full Text] [Related]
4. Raman and CD spectroscopy of recombinant 68-kDa DNA human topoisomerase I and its complex with suicide DNA-substrate.
Fleury F; Ianoul A; Kryukov E; Sukhanova A; Kudelina I; Wynne-Jones A; Bronstein IB; Maizieres M; Berjot M; Dodson GG; Wilkinson AJ; Holden JA; Feofanov AV; Alix AJ; Jardillier JC; Nabiev I
Biochemistry; 1998 Oct; 37(41):14630-42. PubMed ID: 9772192
[TBL] [Abstract][Full Text] [Related]
5. Dumbbell-shaped circular oligonucleotides as inhibitors of human topoisomerase I.
Li X; Tao Ng MT; Wang Y; Liu X; Li T
Bioorg Med Chem Lett; 2007 Sep; 17(17):4967-71. PubMed ID: 17591440
[TBL] [Abstract][Full Text] [Related]
6. Camptothecins inhibit the utilization of hydrogen peroxide in the ligation step of topoisomerase I catalysis.
Lisby M; Krogh BO; Boege F; Westergaard O; Knudsen BR
Biochemistry; 1998 Jul; 37(30):10815-27. PubMed ID: 9692972
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution and functional characterization of the unusual bi-subunit type I DNA topoisomerase from Leishmania donovani.
Das BB; Sen N; Ganguly A; Majumder HK
FEBS Lett; 2004 May; 565(1-3):81-8. PubMed ID: 15135057
[TBL] [Abstract][Full Text] [Related]
8. [The mechanism of specific cleavage of supercoiled DNA by human DNA topoisomerase I: the effect of ligand structure on the catalytic step of reaction].
Bugreev DV; Buneva VN; Nevinskiĭ GA
Mol Biol (Mosk); 2003; 37(2):325-39. PubMed ID: 12723479
[TBL] [Abstract][Full Text] [Related]
9. Conjugated eicosapentaenoic acid inhibits human topoisomerase IB with a mechanism different from camptothecin.
Castelli S; Campagna A; Vassallo O; Tesauro C; Fiorani P; Tagliatesta P; Oteri F; Falconi M; Majumder HK; Desideri A
Arch Biochem Biophys; 2009 Jun; 486(2):103-10. PubMed ID: 19397888
[TBL] [Abstract][Full Text] [Related]
10. Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine.
Benedetti P; Fiorani P; Capuani L; Wang JC
Cancer Res; 1993 Sep; 53(18):4343-8. PubMed ID: 8395982
[TBL] [Abstract][Full Text] [Related]
11. DNA binding induces conformational transition within human DNA topoisomerase I in solution.
Oleinikov V; Sukhanova A; Mochalov K; Ustinova O; Kudelina I; Bronstein I; Nabiev I
Biopolymers; 2002; 67(6):369-75. PubMed ID: 12209444
[TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor protein p53 stimulates the formation of the human topoisomerase I double cleavage complex in vitro.
Søe K; Hartmann H; Schlott B; Stevnsner T; Grosse F
Oncogene; 2002 Sep; 21(43):6614-23. PubMed ID: 12242659
[TBL] [Abstract][Full Text] [Related]
13. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
[TBL] [Abstract][Full Text] [Related]
14. Nick-containing oligonucleotides as human topoisomerase I inhibitors.
Chua ST; Quek NM; Li M; Ng MT; Yuan W; Chua ML; Guo J; Koh LE; Ye R; Li T
Bioorg Med Chem Lett; 2009 Feb; 19(3):618-23. PubMed ID: 19131243
[TBL] [Abstract][Full Text] [Related]
15. Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.
Holden JA; Wall ME; Wani MC; Manikumar G
Arch Biochem Biophys; 1999 Oct; 370(1):66-76. PubMed ID: 10496978
[TBL] [Abstract][Full Text] [Related]
16. An insight into the mechanism of inhibition of unusual bi-subunit topoisomerase I from Leishmania donovani by 3,3'-di-indolylmethane, a novel DNA topoisomerase I poison with a strong binding affinity to the enzyme.
Roy A; Das BB; Ganguly A; Bose Dasgupta S; Khalkho NV; Pal C; Dey S; Giri VS; Jaisankar P; Dey S; Majumder HK
Biochem J; 2008 Jan; 409(2):611-22. PubMed ID: 17922678
[TBL] [Abstract][Full Text] [Related]
17. Early effects of topoisomerase I inhibition on RNA polymerase II along transcribed genes in human cells.
Khobta A; Ferri F; Lotito L; Montecucco A; Rossi R; Capranico G
J Mol Biol; 2006 Mar; 357(1):127-38. PubMed ID: 16427078
[TBL] [Abstract][Full Text] [Related]
18. The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA.
Davies DR; Mushtaq A; Interthal H; Champoux JJ; Hol WG
J Mol Biol; 2006 Apr; 357(4):1202-10. PubMed ID: 16487540
[TBL] [Abstract][Full Text] [Related]
19. Effects of modification of the active site tyrosine of human DNA topoisomerase I.
Gao R; Zhang Y; Dedkova L; Choudhury AK; Rahier NJ; Hecht SM
Biochemistry; 2006 Jul; 45(27):8402-10. PubMed ID: 16819839
[TBL] [Abstract][Full Text] [Related]
20. Functional interactions of DNA topoisomerases with a human replication origin.
Abdurashidova G; Radulescu S; Sandoval O; Zahariev S; Danailov MB; Demidovich A; Santamaria L; Biamonti G; Riva S; Falaschi A
EMBO J; 2007 Feb; 26(4):998-1009. PubMed ID: 17290216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
